Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen Therapeutics Inc.
Chairman and CEO, 10% Owner of Gas Natural Inc (EGAS) Richard M Osborne sold 700,000 shares on 07/02/2012 at an average price of $10.1. Gas Natural Inc., formerly known as Energy, Inc., distributes and sells natural gas to end-use residential, commercial, and industrial customers. Gas Natural Inc has a market cap of $82.4 million; its shares were traded at around $10.19 with a P/E ratio of 24.6 and P/S ratio of 0.8. The dividend yield of Gas Natural Inc stocks is 5.4%. Gas Natural Inc had an annual average earnings growth of 17.1% over the past 10 years.
Gas Natural Inc announced their 2012 first quarter financial results on May 15, 2012. The Company reported net income of $3.3 million and total revenues of $33.8 million.
Chairman and CEO, 10% Owner Richard M Osborne sold 700,000 shares of EGAS stock on 07/02/2012 at the average price of 10.1.
Encore Bancshares Inc (EBTX): Chairman and CEO James Samuel Dagostino Jr sold 597,612 Shares
Chairman and CEO of Encore Bancshares, Inc (EBTX) James Samuel Dagostino Jr sold 597,612 shares on 07/02/2012 at an average price of $20.62. Encore Bancshares, Inc. is a bank holding company headquartered in Houston, Texas and offers a broad range of banking, wealth management and insurance services through its main subsidiary Encore Bank, N. with a P/E ratio of 62.5 and P/S ratio of 2.7.
On April 27, Encore Bancshares reported net income of $3.2 million in their 2012 first quarter financial earnings.
Chairman and CEO James Samuel Dagostino Jr sold 607,612 shares of EBTX stock in June and July. EVP and CFO Patrick Timothy Oakes sold 12,500 shares of EBTX stock on 07/02/2012 at the average price of 20.62. Director Edwin E. Smith, 10% Owner J. Harold Williams, Director Walter M. Jr. Mischer, Director Eugene H. Vaughan, and Director Randa Duncan Williams sold 1,039,912 shares of EBTX stock on 07/02/2012.
Staples Inc. (SPLS): Chairman and CEO Ronald Sargent sold 480,000 Shares
Chairman and CEO of Staples, Inc. (SPLS) Ronald Sargent sold 480,000 shares on 06/29/2012 at an average price of $12.73. Staples.com is creating a business-to-business electronic marketplace offering a comprehensive solution for all of the officeneeds of business customers. Staples, Inc. has a market cap of $9.04 billion; its shares were traded at around $13.22 with a P/E ratio of 9.3 and P/S ratio of 0.4. The dividend yield of Staples, Inc. stocks is 3.4%. Staples, Inc. had an annual average earnings growth of 11.2% over the past 10 years. GuruFocus rated Staples, Inc. the business predictability rank of 3-star.
Total Company sales were $6.1 billion and net income was $187 million for Staples Inc’s 2012 first quarter financial results.
Chairman and CEO Ronald Sargent sold 513,300 shares of SPLS stock in March and June. President, US Stores Demos Parneros and Directors Mary Elizabeth Burton, Paul Walsh, Robert Nakasone, and Basil Anderson sold 155,374 shares of SPLS stock in March.
Orexigen Therapeutics Inc. (OREX): President and CEO Michael Narachi sold 225,000 Shares
President and CEO of Orexigen Therapeutics, Inc. (OREX) Michael Narachi sold 225,000 shares on 06/29/2012 at an average price of $5.89. OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. Orexigen Therapeutics, Inc. has a market cap of $376.5 million; its shares were traded at around $5.78 with and P/S ratio of 109.7.
Orexigen Therapeutics Inc reported net loss of $10.4 million and revenues of $857,000 for their 2012 first quarter results.
President and CEO Michael Narachi sold 225,000 shares of OREX stock on 06/29/2012 at the average price of 5.89. The price of the stock has decreased by 1.87% since. Chief Business Officer Joseph P Hagan and Chief Commercial Officer Mark D Booth sold 211,309 shares of OREX stock in June.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.